Page 141 - 《中国药房》2025年10期
P. 141

中药活性成分靶向线粒体凋亡途径抑制食管癌的研究进展
                                                                                                   Δ


                                                           3 #
          肖俊珂 ,慕晓艳 ,郭娇娇 ,杨上智 ,曹雪炜 ,郭志忠 (1.河南中医药大学第二临床医学院,郑州 450002;
                 1*
                                                   1
                                           1
                          2
                                  1
          2.上海中医药大学附属龙华医院肿瘤科,上海 200032;3.河南省中医院/河南中医药大学第二附属医院肿瘤
          科,郑州 450002)
          中图分类号  R965;R735.1      文献标志码  A      文章编号  1001-0408(2025)10-1283-06
          DOI  10.6039/j.issn.1001-0408.2025.10.23

          摘  要  食管癌是一种恶性疾病,其发病率高、预后差。线粒体凋亡途径在调控细胞死亡中起着重要作用,是当前癌症治疗的研
          究热点。多种中药活性成分可靶向线粒体凋亡抑制食管癌,是食管癌的潜在治疗药物。本文对中药活性成分通过靶向线粒体凋
          亡途径抑制食管癌的相关研究进行综述,发现黄酮类(如紫花牡荆素、淫羊藿苷、木犀草素、山柰酚、橙皮素、鱼藤素等)、萜类(如冬
          凌草甲素、Jaridonin、青蒿琥酯、阿魏菇乙酸乙酯相三萜类化合物等)、生物碱类(如苦参碱、苦马豆素等)、酚类(如姜黄素、表没食
          子儿茶素-3-没食子酸酯、柯里拉京等)、皂苷类(如α-常春藤皂苷、重楼皂苷Ⅵ等)、多肽类(如蝎毒多肽优化体CT-K3K7、壁虎多肽
          等)、挥发油类(如肉桂醛、α-细辛醚等)等中药活性成分可以通过调节氧化应激、阻滞细胞周期、调控磷脂酰肌醇3-激酶/蛋白激酶B、
          丝裂原激活的蛋白激酶等信号通路,靶向内源性线粒体凋亡途径,诱导食管癌细胞发生凋亡,并抑制食管癌细胞的增殖、侵袭及
          迁移。
          关键词  中药;活性成分;食管癌;线粒体凋亡;细胞凋亡;作用机制

          Research  progress  on  active  components  of  traditional  Chinese  medicine  inhibiting  esophageal  carcinoma
          by targeting mitochondrial apoptosis pathway
                                                               1
                                                                            1
                    1
                                               1
                                 2
          XIAO Junke ,MU Xiaoyan ,GUO Jiaojiao ,YANG Shangzhi ,CAO Xuewei ,GUO Zhizhong(1. Second Clinical
                                                                                           3
          Medical  College,  Henan  University  of  Chinese  Medicine,  Zhengzhou  450002,  China;2.  Dept.  of  Oncology,
          Longhua  Hospital Affiliated  to  Shanghai  University  of Traditional  Chinese  Medicine,  Shanghai  200032,  China;
          3. Dept. of Oncology, Henan Provincial Hospital of Traditional Chinese Medicine/the Second Affiliated Hospital
          of Henan University of Chinese Medicine, Zhengzhou 450002, China)
          ABSTRACT   Esophageal  carcinoma  is  a  malignant  disease  with  a  high  incidence  rate  and  poor  prognosis.  The  mitochondrial
          apoptosis  pathway  plays  a  pivotal  role  in  the  regulation  of  cell  death  and  has  become  a  focal  point  in  current  cancer  therapeutics
          research.  Various  active  components  from  traditional  Chinese  medicine (TCM)  can  target  the  mitochondrial  apoptosis  pathway  to
          inhibit esophageal carcinoma, presenting as potential therapeutic agents for this disease. This paper summarizes relevant research on
          the inhibition of esophageal carcinoma by active components in TCM via targeting the mitochondrial apoptosis pathway. It has been
          found  that  flavonoids (casticin,  icariin,  luteolin,  kaempferol,  hesperetin,  deguelin,  etc.),  terpenoids (oridonin,  Jaridonin,
          artesunate,  ethyl  acetate  fraction  of  pleurotus  ferulatus  triterpenoid,  etc.),  alkaloids (matrine,  swainsonine,  etc.),  polyphenols
         (curcumin,  epigallocatechin-3-gallate,  corilagin,  etc.),  steroids (α-hederin,  polyphyllin  Ⅵ,  etc.),  phenols (optimized  scorpion
          venom  peptide  CT-K3K7,  gecko  active  polypeptide,  etc.),  volatile  oils (cinnamaldehyde,  α -asarone,  etc.)  and  other  active
          components  from  TCM  can  target  the  intrinsic  mitochondrial  apoptosis  pathway,  induce  apoptosis  in  esophageal  carcinoma  cells,
          and  inhibit  their  proliferation,  invasion  and  migration  by  regulating  oxidative  stress,  blocking  the  cell  cycle,  regulating  signaling
          pathways such as PI3K/Akt and MAPK.
          KEYWORDS    traditional  Chinese  medicine;  active  components;  esophageal  carcinoma;  mitochondrial  apoptosis;  cell  apoptosis;

                                                             mechanism of action
             Δ 基金项目 河南省科技攻关项目(No.242102311287);河南省中
          医药科学研究专项(No.2022ZYZD11);上海中医药大学附属龙华医院
         “龙医学者”临床科技创新项目(No.KC2022015)                            2022年全球癌症数据分析显示,食管癌在所有癌症
             *第一作者 硕士研究生。研究方向:中医药防治恶性肿瘤。E-                                                   [1]
                                                             中的发病率居第9位,死亡率排第6位 。在中国每年约
          mail:xjk17839956234@163.com
                                                             有32万人死于食管癌,患者总体5年生存率仅为15%~
             # 通信作者 主任医师,硕士生导师。研究方向:中医药防治恶性
          肿瘤。E-mail:fangliao0525@163.com                     25%,迫切需要开发有效的药物或治疗方案为食管癌的


          中国药房  2025年第36卷第10期                                              China Pharmacy  2025 Vol. 36  No. 10    · 1283 ·
   136   137   138   139   140   141   142   143   144   145   146